Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00634270
Brief Title: A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas (Protocol 102)

First Submitted : February 20, 2008
First Submitted that Met QC Criteria : March 12, 2008
First Posted : March 13, 2008 (Estimate)

Results First Submitted : July 3, 2015
Results First Submitted that Met QC Criteria : December 21, 2016
Results First Posted : February 14, 2017

Last Update Submitted that Met QC Criteria : October 12, 2017
Last Update Posted : November 17, 2017